08 Mart 2026

Average Rating

5 Star
5%
4 Star
27%
3 Star
18%
2 Star
27%
1 Star
23%
2.60
(Add your review)

44 thoughts on “Şirvan Kərimovun oğlunun intiharında “MAVİ BALİNA” İZİ”

  2. 78153 258391An attention-grabbing discussion is worth comment. I believe which you really should write a lot more on this matter, it wont be a taboo subject nonetheless normally persons are not sufficient to talk on such topics. Towards the next. Cheers 791083

  4. 379556 895136I adore foregathering beneficial information, this post has got me even more information! . 745962

  7. 984783 154938An fascinating discussion is worth comment. I think that you really should write a lot more on this topic, it may well not be a taboo topic but usually men and women are not enough to speak on such topics. Towards the next. Cheers 661386

  9. 844612 700078A person essentially lend a hand to make significantly articles I may well state. That may be the quite initial time I frequented your site page and up to now? I amazed with the research you created to create this particular publish incredible. Excellent activity! 983340

  11. 170495 122615Heya just wanted to give you a brief heads up and let you know some with the pictures arent loading properly. Im not positive why but I believe its a linking concern. Ive tried it in two different internet browsers and both show the same outcomes. 318900

  16. 802291 868278Ive writers block that comes and goes and I want to uncover a approach to get rid of my writers block. It can occasionally be so bad I can barley make sentences. Any ideas? 367799

  18. Guide To CJC-1295: Efficiency And Proper Use

    Guide To CJC‑1295: Efficiency And Proper Use

    —

    What is CJC‑1295 and How to Get the Most Out of It

    CJC‑1295 is a synthetic peptide that mimics growth hormone‑releasing hormone (GHRH).
    By stimulating the pituitary gland, it boosts the secretion of human growth hormone
    (hGH) and insulin‑like growth factor 1 (IGF‑1).
    Because of its potent ability to elevate these hormones
    over an extended period, CJC‑1295 is popular among athletes,
    bodybuilders, and individuals seeking anti‑aging benefits.
    To maximize its effectiveness, one must understand its mechanism, optimal combinations with other peptides, proper dosing schedules,
    and realistic expectations regarding results.

    —

    What is CJC‑1295?

    cjc 1295 and ipamorelin combination side effects‑1295 belongs to the GHRH family of analogues.

    It contains a cyclic structure that protects
    it from rapid degradation by peptidases, giving it a half‑life of up to 30 hours in some
    formulations. This long duration allows for once‑daily injections
    while maintaining sustained growth hormone stimulation. The peptide is usually supplied as a lyophilized powder
    that must be reconstituted with bacteriostatic water before injection.

    —

    What is CJC‑1295 used for?

    Muscle hypertrophy and recovery – Higher hGH levels promote protein synthesis and reduce muscle breakdown, aiding in faster post‑workout repair.

    Fat loss – Growth hormone increases lipolysis, helping to mobilize fat stores without significant appetite changes.

    Anti‑aging – IGF‑1 supports skin elasticity, joint lubrication,
    and cellular repair processes.

    Enhanced sleep quality – Many users report deeper,
    more restorative REM cycles during treatment.

    Improved endurance – Increased glycogen synthesis in muscles can extend workout
    capacity.

    Use of CJC‑1295 with DAC

    DAC (Drug Affinity Complex) refers to a polyethylene glycol (PEG) or other carrier attached to
    the peptide, which further extends its half‑life. The combination of CJC‑1295 with a
    DAC is often labeled CJC‑1295 DAC. This version can be injected once per week instead of daily because the PEGylated form
    remains active for 1–2 weeks. For those who prefer less frequent
    dosing, CJC‑1295 DAC offers convenience without sacrificing hormonal stimulation.

    —

    Use of CJC‑1295 and Ipamorelin

    Ipamorelin is a selective ghrelin receptor agonist that also stimulates growth hormone
    release but through a different pathway. Pairing CJC‑1295 with Ipamorelin creates a synergistic effect:
    CJC‑1295 provides sustained basal stimulation,
    while Ipamorelin triggers rapid surges during the injection period.
    This combination is often called a “dual‑peptide protocol” and can lead to higher peak hGH levels than either peptide alone.

    Typical pairing involves:

    CJC‑1295 (30–50 µg) once daily at bedtime

    Ipamorelin (10–20 µg) immediately after CJC‑1295 injection

    The result is a prolonged hormone profile with an initial spike followed
    by steady maintenance.

    How to take CJC‑1295 effectively

    Reconstitution – Dissolve the lyophilized powder in 0.9% saline or bacteriostatic
    water, typically achieving 100 µg/mL concentration.

    Injection site – Use the subcutaneous space (abdomen, thigh, upper arm) for optimal absorption. Rotate sites to avoid lipohypertrophy.

    Timing – Inject in the evening or before bed; growth hormone secretion is naturally higher during sleep, and the peptide’s long half‑life aligns with this circadian rhythm.

    Hydration – Maintain adequate water intake to support kidney clearance of the peptide metabolites.

    Monitoring – Keep a log of doses, injection times, and subjective changes (energy, sleep,
    recovery). Adjust if needed after 4–6 weeks.

    CJC‑1295 Dosage

    Daily protocol: 30 µg to 50 µg per day is common.

    Weekly DAC protocol: 100 µg to 150 µg once a week.

    Combined with Ipamorelin: Add 10–20 µg of Ipamorelin on the same day as CJC‑1295
    for peak stimulation.

    Begin at the lower end, especially if new
    to peptide therapy, and titrate upward every few weeks based on response and tolerance.

    What results to expect from CJC‑1295?

    Category Expected Outcome

    Muscle mass 1–2 kg increase over 12 weeks with concurrent resistance
    training

    Fat loss 0.5–1 kg per month, more pronounced
    in abdominal region

    Recovery Reduced muscle soreness within 24 hours post‑workout

    Sleep Deeper REM cycles, quicker onset of sleep

    Skin & joints Improved elasticity, reduced joint
    stiffness after 8–12 weeks

    Individual responses vary; consistency and proper diet play critical roles.

    —

    Benefits

    Sustained growth hormone elevation without daily injections (DAC form).

    Reduced risk of hypoglycemia compared to synthetic hGH.

    Improved anabolic environment for muscle repair and fat
    oxidation.

    Minimal impact on appetite, making it suitable for weight‑management goals.

    Side effects

    Mild injection site reactions: redness, swelling, or tenderness.

    Temporary water retention in extremities.

    Rare cases of joint pain or tingling when doses are high.

    Long‑term safety data is limited; monitor hormone levels and
    consult a healthcare professional regularly.

    Get Free Consultation

    If you’re considering integrating CJC‑1295 into your routine, many specialized clinics offer complimentary initial assessments to discuss dosage, potential interactions, and monitoring plans tailored to your goals.

    —

  33. First Time User, Anavar Only Cycle Pharma TRT

    **Testosterone Management – Practical Guidance for Clinicians (July 2024)**

    | Section | Key Points & Actions |
    |———|———————|
    | **1️⃣ Definition & Role** | • Primary male sex hormone; key in muscle mass, bone density, libido, mood, and red‑cell production.
    • Normal adult serum total testosterone ≈ 300–1000 ng/dL (10–35 nmol/L).

    • Decline ≥ 1–2 % per year after age 30. |
    | **2️⃣ Baseline Assessment** | • **History**: ED, low libido, fatigue,
    mood changes, decreased muscle mass, osteoporosis risk.

    • **Physical**: BMI, body composition, DEXA if indicated, blood pressure, signs of hypogonadism (gynecomastia,
    testicular atrophy).
    • **Labs** (first morning 7–9 a.m.):
     - Total testosterone (TT)
     - Sex Hormone Binding Globulin (SHBG) & calculate
    free testosterone (FT)
     - LH/FSH to differentiate primary vs secondary hypogonadism
     - Estradiol, prolactin, thyroid panel, CBC, CMP, lipid profile.

    • **Repeat TT** if initial value 500 ng/dL (to confirm).

    • **Clinical correlation**: symptoms of low T, libido, erectile dysfunction, mood, energy,
    body composition, bone health, etc. |
    | **3. 1‑year follow‑up and monitoring plan** | • Schedule visit at 12 months to assess adherence, side‑effects, lab values, and symptom
    improvement.
    • Repeat CBC, CMP, lipid profile, PSA, prolactin, TSH, free T4 (if using
    testosterone therapy).
    • Re‑measure body composition (DXA if
    available) or use surrogate markers (BMI, waist circumference).

    • Monitor for adverse events: erythrocytosis, thrombocytopenia, hypertension, liver dysfunction,
    mood changes.
    • Assess sexual function and quality of life using validated questionnaires.
    |
    | **B. Evidence‑Based Rationale** | 1. **Metabolic syndrome prevalence** among patients with PCOS is high (≈70 %) and includes
    central obesity, insulin resistance, dyslipidemia, hypertension – all components of metabolic syndrome.^1 2.
    **Insulin resistance** is the principal driver;
    hyperinsulinemia promotes androgen synthesis and impairs SHBG production, leading to increased free testosterone.^2 3.
    **Lifestyle modification** (diet + exercise) reduces insulin levels by >30 % and improves lipid profiles
    and BP in PCOS patients – meta‑analyses show significant reductions
    in waist circumference, fasting glucose, triglycerides,
    LDL, and BP.^3 4. **Metformin** decreases hepatic gluconeogenesis,
    enhances peripheral insulin sensitivity, lowers androgen production, and is associated with weight
    loss (0.5–1 kg on average) and improved ovulation rates.^4 5.
    **Anti‑androgen therapy** (spironolactone) directly blocks androgen receptors in the pilosebaceous unit, reducing
    sebum output; dose‑response studies confirm
    decreased sebum excretion with higher serum concentrations of
    spironolactone up to 200 mg/day.^5 6. **Topical retinoids** normalize follicular keratinization,
    leading to a reduction in comedones and inflammatory lesions; controlled
    trials report a mean reduction of 30–50% in lesion counts after 12 weeks of isotretinoin therapy.^6 7.
    **Benzoyl peroxide** exerts bactericidal effects
    against *C. acnes*; microbiological assays show >99 % kill rates at
    concentrations ≥2.5 %.^7

    The mechanistic pathways above provide the biological plausibility for each therapeutic modality, which is
    then validated in clinical settings through randomized controlled trials and meta‑analyses.

    —

    ### 4. Evidence‑Based Recommendations

    Below are the distilled recommendations from major guidelines (American Academy of Dermatology – AAD, European Society of Dermatology – ESID,
    NICE). All evidence levels are indicated.

    | **Condition** | **First‑Line Therapy** | **Evidence Level / Grade** |
    |—————|————————|—————————|
    | Acne vulgaris (mild–moderate) | Topical retinoid +
    benzoyl peroxide | AAD 1b; NICE B |
    | Acne vulgaris (severe, nodulocystic) | Oral doxycycline 100 mg BID or oral isotretinoin | AAD 1a; NICE
    A |
    | Rosacea (erythematotelangiectatic) | Topical metronidazole 0.75% gel + oral doxycycline 100 mg BID | AAD 2b; NICE B |
    | Rosacea (papulopustular) | Oral doxycycline 200 mg daily + topical ivermectin 12% cream | AAD 1b; NICE C |
    | Dermatitis (atopic) | Topical clobetasol propionate 0.05% ointment, twice daily for 7 days | AAD 2c; NICE B |
    | Acne vulgaris (moderate) | Oral isotretinoin 0.5 mg/kg/day
    until cumulative dose of 120–150 mg/kg | AAD 1a; NICE C |

    —

    ## 4 – 5‑Year Plan to Become a Dermatologist

    | Year | Educational & Clinical Steps | Key Actions |
    |——|——————————|————-|
    | **0** (Age 20) | **Undergraduate Degree** in Biology/Health Sciences.
    | Take core courses: organic chemistry, biochemistry,
    genetics. Join research or clinical volunteer projects. |
    | **1–2** | **Clinical Exposure & Research** | Shadow dermatologists;
    complete a summer internship at a hospital’s dermatology department.
    Publish a short paper or poster on skin pathology or public‑health dermatology.
    |
    | **3–4** | **Medical School Applications** | Maintain GPA ≥ 3.7;
    score ≥ 540 on MCAT. Attend interviews with dermatology programs.
    |
    | **5–8** | **MD Program** | • First two years: core medical knowledge, including dermatology
    rotations in year 2.
    • Third‑year electives: attend multiple dermatology clinics and conferences (e.g., American Academy of Dermatology).

    • Fourth‑year: complete a 6–12 month research project on dermatologic disease prevalence or new treatment modalities,
    culminating in publication. |
    | **9** | **Residency Application** | Submit applications through ERAS with
    strong letters from dermatologists and research supervisors.
    |
    | **10–13** | **Dermatology Residency (3 years)** | • Year‑1:
    basic procedural skills (biopsies, excisions).
    • Year‑2: advanced procedures (laser therapy, Mohs surgery).

    • Year‑3: sub‑specialty electives, leadership roles in clinical rotations.
    |
    | **14** | **Board Certification Exam** | Pass the American Board of Dermatology exam.
    |
    | **15–16** | **Optional Fellowship (1–2 years)** | Focus
    on a sub‑specialty: Mohs micrographic surgery, dermatopathology,
    cosmetic dermatology, pediatric dermatology, etc., depending on career goals.

    |

    *Total time from high school graduation to full board certification:*
    **~14 years** (including optional fellowship).

    —

    ## 3. Typical Educational Pathway

    | Step | Typical Age | Duration | What Happens |
    |——|————-|———-|————–|
    | High‑school diploma | 17–18 | N/A | Finish core curriculum, prepare for college entrance exams (SAT/ACT).

    |
    | Undergraduate degree | 18–22 | 4 yrs | Choose a major (often biology, chemistry, or pre‑med).
    Take prerequisite courses for medical school. |
    | Medical school | 22–26 | 4 yrs | Attend lecture, labs, clinical rotations in internal medicine,
    surgery, pediatrics, etc. Earn MD degree. |
    | Residency (internal medicine) | 26–29 | 3 yrs | Work full‑time under supervision at hospitals; focus on adult internal medicine.
    |
    | Fellowship (cardiology) | 29–32+ | 3+ yrs | Specialize in heart disease: electrophysiology, interventional cardiology, heart
    failure, etc. |

    **Key milestones for a cardiologist:**

    – **Pass USMLE Step exams** (if in the U.S.) or equivalent licensing examinations.

    – **Complete an accredited internal‑medicine residency** (3 years).

    – **Obtain board certification** from the American Board of Internal Medicine (ABIM) after residency and
    examination.
    – **Enroll in a cardiology fellowship** at a recognized institution; complete 3–4 years of training.

    – **Earn ABIM subspecialty certification** in Cardiology after fellowship
    completion and passing the specialty exam.

    —

    ## 2. Pathway to Becoming an American Cardiologist

    | Step | Description | Typical Duration |
    |——|————-|——————|
    | **High School → Undergraduate (B.S.)** | Strong GPA, AP/IB courses, extracurriculars (volunteer
    work, research). Apply to colleges; may need SAT/ACT scores.
    | 4 yrs |
    | **Undergraduate + Pre‑Medical Coursework** | Complete required science electives:
    biology, chemistry, physics, math. Many students double major in Biology or Chemistry.
    | 4 yrs |
    | **Apply to Medical School (M‑A‑P)** | Submit AMCAS application, MCAT score
    (~31–34), letters of recommendation, personal statement.

    Attend interviews at schools. | N/A (application period) |
    | **Medical School** | MD program: preclinical years (Anatomy, Physiology, Biochemistry).
    Clinical rotations in internal medicine, surgery, pediatrics,
    OB‑GYN, psychiatry, etc. Earn medical license after graduation and passing USMLE Step 1 & 2.
    | 4 yrs |
    | **Residency – Internal Medicine** | PGY‑1: general internal medicine clerkships (cardiology,
    endocrinology, infectious disease, gastroenterology, etc.).

    | 1 yr |
    | **Fellowship – Infectious Disease** | PGY‑2 & PGY‑3: specialized training in ID: inpatient and
    outpatient ID services, HIV care, TB management, transplant immunosuppression, critical care ID.

    | 2 yrs |
    | **Clinical Practice – Infectious Disease** | Full clinical practice after fellowship completion; may continue to work at the same institution or elsewhere.
    | Ongoing |

    —

    ## 2. Clinical Practice in Infectious Diseases

    ### Core Responsibilities
    | Domain | Key Activities | Typical Time Allocation |
    |——–|—————-|————————–|
    | **Inpatient Consults** | – Evaluate patients with suspected/severe infections.

    – Order cultures, imaging, and lab tests.
    – Draft antimicrobial plans (choice, dose, duration).

    – Review microbiology reports and adjust therapy. |
    40–50 % |
    | **Outpatient Clinic** | – Follow-up on chronic infections (e.g., endocarditis, HIV,
    TB).
    – Prescribe long‑term suppressive therapy.
    – Counsel patients on medication adherence. | 30–35 % |
    | **Antimicrobial Stewardship** | – Participate in stewardship rounds.

    – Develop local antibiotic guidelines.
    – Review antibiotic usage data and provide feedback to
    prescribers. | 10–15 % |
    | **Diagnostics/Consultations** | – Provide expertise on complex cultures, molecular
    diagnostics, or emerging resistance mechanisms.
    – Consult with other specialties (ICU, oncology). | 5–10 % |

    > **Key Takeaway:** In a typical setting, around **70‑75 %** of your time will be spent
    on direct patient care and stewardship activities; the remaining **25‑30 %** involves diagnostics,
    education, and research.

    —

    ## 3. How to Manage Time Efficiently

    | Strategy | Why It Works | Practical Steps
    |
    |———-|————–|—————–|
    | **Batch similar tasks** (e.g., chart review in one block) | Reduces
    context‑switching fatigue | Allocate a 30‑min slot for chart reviews,
    then move on to patient visits. |
    | **Use “micro‑breaks”** | Recharges mental focus | Stand up,
    stretch, or glance at something outside the room every 20–25 min. |
    | **Leverage technology** (e.g., dictation, voice‑activated EMR)
    | Cuts down typing time | Practice voice‑to‑text for orders and progress notes;
    use templates. |
    | **Set “do‑not‑interrupt” windows** | Protects deep work from interruptions |
    Post a sign on your desk or set an auto‑reply indicating you’re in the middle of patient care.
    |
    | **Prioritize tasks before entering the office** | Reduces decision fatigue | Make
    a quick to‑do list: what must be done today? Which tasks can wait until
    after the shift? |

    —

    ## 3️⃣ The “Brain‑Friendly” Work Routine

    ### Morning (Start‑Up Phase)
    – **5–10 min of mindful breathing or body scan** → sets calm baseline.

    – **Quick review of agenda & priority list** → aligns expectations.

    ### During Patient Visits
    – Use a **”mental note‑taking” strategy**: silently label
    each new piece of information with an emoji ( for vitals, for red
    flags) – this keeps your brain focused without pulling out the pen.

    ### Mid‑Shift Break
    – **Micro‑movement**: 30 sec standing stretch or hand/arm rolls.

    – **Hydrate & snack**: anavar 50mg a day results handful
    of nuts or fruit to maintain glucose levels.

    ### End of Shift Reflection (5–10 min)
    – Write 2–3 things you learned and one area for improvement.
    This solidifies memory consolidation during sleep.

    —

    ## Final Take‑away

    Your brain is not just a passive receiver; it actively organizes, consolidates, and refines information. By leveraging *attention*, *sleep* (especially
    REM), *repetition*, *multimodal encoding*, *contextual cues*,
    and *active retrieval*, you can transform each patient interaction into a lasting memory that fuels your clinical expertise.

    Remember: the next time you review notes after a shift, give yourself an extra minute to mentally rehearse key
    points, engage in a brief walk or stretch, and allow your mind to
    rest. Your future self—your more seasoned practitioner—will thank you.

    Good luck on this fascinating journey of learning and memory!

Bir cavab yazın

Sizin e-poçt ünvanınız dərc edilməyəcəkdir. Gərəkli sahələr * ilə işarələnmişdir

Oxşar mövzular

5acae33a-45fa-32ac-900c-a27123f9461e_850

Sumqayıtda restoranda baş verən yanğın söndürülüb

xaber-redaktor 28 Sentyabr 2024 0
fazil_81680029584

Azərbaycanda deputat yaşadığı evin qarşısında güllələndi – YENİLƏNİB + TƏFƏRRÜAT

admin 29 Mart 2023 0
641d6f250ad3a641d6f250ad3b1679650597641d6f250ad38641d6f250ad39

İranda zəlzələ nəticəsində 165 nəfər yaralanıb

admin 24 Mart 2023 0

Bütün yazılar

OD2QnCBznwUs6Sial1XhEPLYVTwJFvkF3mI7eOop_640

Sayman Aruz: “İran hakimiyyəti yaxşı bilir ki, Təbriz qalxarsa…”

xaber-redaktor 06 Yanvar 2026 0
ac3f6578eb_86699

Həmid Herisçi ard-arda Təbrizə səfər etməklə İran molla rejiminin tapşırıqlarını Azərbaycan Yazıçılar Birliyində həyata keçirib? – SENSASİON İDDİA

xaber-redaktor 30 Dekabr 2025 0
1632737255_0aq-2(1).jpg

Vətən müharibəsinin xronikası: 31 OKTYABR

admin 01 Noyabr 2025 0
0b1690a307b5d22.jpg

Prezident İlham Əliyev Rumıniya Parlamenti Senatının sədrini qəbul edib

admin 01 Noyabr 2025 0